Pro-apoptotic role of nuclear factor-κB in adriamycin-induced acute myocardial injury in rats

Molecular Medicine Reports

Volumn 5, Issue 2, 2012, Pages 400-404

  Wang, Fang ^a   Li, Hongli ^a   Shi, Haoying ^a   Sun, Baogui ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Adriamycin; Apoptosis; Myocardium; Nuclear factor B; Pyrrolidine dithiocarbamate

Indexed keywords

DOXORUBICIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P53; PYRROLIDINE DITHIOCARBAMATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; HEART MUSCLE INJURY; IMMUNOHISTOCHEMISTRY; MALE; NICK END LABELING; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ACUTE DISEASE; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; DNA DAMAGE; DOXORUBICIN; GENE EXPRESSION REGULATION; HEART INJURIES; IN SITU NICK-END LABELING; MALE; NF-KAPPA B; PROTEIN BINDING; RATS; RATS, WISTAR; TUMOR SUPPRESSOR PROTEIN P53;

RATTUS; RATTUS NORVEGICUS;

EID: 84862909187     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.636     Document Type: Article

References (28)

1. Abou-Alfa GK, Johnson P, Knox JJ, Capanu M, Davidenko I, Lacava J, Leung T, Gansukh B and Saltz LB: Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial. JAMA 304: 2154-2160, 2010.
2. Van Lummel M, van Blitterswijk WJ, Vink SR, Veldman RJ, van der Valk MA, Schipper D, Dicheva BM, Eggermont AM, ten Hagen TL, Verheij M and Koning GA: Enriching lipid nanovesicles with short-chain glucosylceramide improves doxorubicin delivery and efficacy in solid tumors. FASEB J 25: 280-289, 2011.
3. Hequet O, Le QH and Moullet I: Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults. J Clin Oncol 22: 1864-1871, 2004. (Pubitemid 41095177)
4. Lipshultz SE, Rifai N and Dalton VM: The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia. N Engl J Med 351: 145-153, 2004. (Pubitemid 38886649)
5. McTiernan CF: Fighting doxorubicin-induced cardiotoxicity with adiponectin. Cardiovasc Res 89: 262-264, 2011.
6. Soni H, Pandya G, Patel P, Acharya A, Jain M and Mehta AA: Beneficial effects of carbon monoxide-releasing molecule-2 (CORM-2) on acute doxorubicin cardiotoxicity in mice: role of oxidative stress and apoptosis. Toxicol Appl Pharmacol 253: 70-80, 2011.
7. Lou H, Danelisen I and Singal PK: Involvement of mitogen-activated protein kinases in adriamycin-induced cardiomyopathy. Am J Physiol Heart Circ Physiol 288: H1925-H1930, 2005. (Pubitemid 40418022)
8. Li H, Gu H and Sun B: Protective effects of pyrrolidine dithiocarbamate on myocardium apoptosis induced by adriamycin in rats. Int J Cardiol 114: 159-165, 2007. (Pubitemid 44791504)
9. Kim SB, Kim JS, Lee JH, et al: NF-κB activation is required for cisplatin-induced apoptosis in head and neck squamous carcinoma cells. FEBS Lett 580: 311-318, 2006. (Pubitemid 43005354)
10. Chong ZZ, Li F and Maiese K: Erythropoietin requires NF-κB and its nuclear translocation to prevent early and late apoptotic neuronal injury during beta-amyloid toxicity. Curr Neurovasc Res 2: 387-399, 2005. (Pubitemid 41789605)
11. Cadeddu C, Piras A, Mantovani G, Deidda M, Dessì M, Madeddu C, Massa E and Mercuro G: Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment. Am Heart J 160: 487.e1-e7, 2010.
12. Di X, Shiu RP, Newsham IF and Gewirtz DA: Apoptosis, autophagy, accelerated senescence and reactive oxygen in the response of human breast tumor cells to adriamycin. Biochem Pharmacol 77: 1139-1150, 2009.
13. Mukherjee S, Banerjee SK, Maulik M, Dinda AK, Talwar KK and Maulik SK: Protection against acute adriamycin-induced cardiotoxicity by garlic: role of endogenous antioxidants and inhibition of TNF-alpha expression. BMC Pharmacol 3: 16, 2003.
14. Mohamed HE, Asker ME, Ali SI and Fattah TM: Protection against doxorubicin cardiomyopathy in rats: role of phosphodiesterase inhibitors type 4. Pharm Pharmacol 56: 757-768, 2004. (Pubitemid 38801692)
15. Dudnakova TV, Lakomkin VL, Tsyplenkova VG, Shekhonin BV, Shirinsky VP and Kapelko VI: Alterations in myocardial cytoskeletal and regulatory protein expression following a single doxorubicin injection. J Cardiovasc Pharmacol 41: 788-794, 2003. (Pubitemid 36523183)
16. RVitelli M, Filippelli A and Rinaldi B: Effects of docosahexaenoic acid on Ca2+(i) increase induced by doxorubicin in ventricular rat cardiomyocytes. Life Sci 71: 1905-1916, 2002.
17. Zhou S, Heller LJ and Wallace KB: Interference with calcium-dependent mitochondrial bioenergetics in cardiac myocytes isolated from doxorubicin-treated rats. Toxicol Appl Pharmacol 175: 60-67, 2001. (Pubitemid 32783536)
18. Wu S, Ko YS and Teng MS: Adriamycin-induced cardiomyocyte and endothelial cell apoptosis: in vitro and in vivo studies. J Mol Cell Cardiol 34: 1595-1607, 2002. (Pubitemid 35454475)
19. Zhao W, Lu L, Chen SS and Sun Y: Temporal and spatial characteristics of apoptosis in the infarcted rat heart. Biochem Biophys Res Commun 325: 605-611, 2004. (Pubitemid 39458038)
20. Takada Y, Ichikawa H, Badmaev V and Aggarwal BB: Acetyl-11-keto-beta- boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-κB and NF-κB-regulated gene expression. J Immunol 176: 3127-3140, 2006.
21. Bakker TR, Reed D, Renno T and Jongeneel CV: Efficient adenoviral transfer of NF-κB inhibitor sensitizes melanoma to tumor necrosis factor-mediated apoptosis. Int J Cancer 80: 320-323, 1999. (Pubitemid 29001739)
22. Arlt A, Vorndamm J, Breitenbroich M, Folsch UR, Kalthoff H, Schmidt WE and Schafer H: Inhibition of NF-κB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin. Oncogene 20: 859-868, 2001. (Pubitemid 32198179)
23. Sumitomo M, Tachibana M, Ozu C, Asakura H, Murai M, Hayakawa M, Nakamura H, Takayanagi A and Shimizu N: Induction of apoptosis of cytokine-producing bladder cancer cells by adenovirus-mediated IκBalpha overexpression. Hum Gene Ther 10: 37-47, 1999. (Pubitemid 29046144)
24. Ricca A, Biroccio A, Trisciuoglio D, Cippitelli M, Zupi G and Del Bufalo D: relA over-expression reduces tumorigenicity and activates apoptosis in human cancer cells. Br J Cancer 85: 1914-1921, 2001.
25. Brozovic S, Sahoo R, Barve S, Shiba H, Uriarte S, Blumberg RS and Kinane DF: Porphyromonas gingivalis enhances FasL expression via up-regulation of NFκB-mediated gene transcription and induces apoptotic cell death in human gingival epithelial cells. Microbiology 152: 797-806, 2006.
26. Peng Y, Gallagher SF, Haines K, Baksh K and Murr MM: Nuclear factor-κB mediates Kupffer cell apoptosis through transcriptional activation of Fas/FasL. J Surg Res 130: 58-65, 2006. (Pubitemid 43028565)
27. Cavin LG, Wang F, Factor VM, Kaur S, Venkatraman M, Thorgeirsson SS and Arsura M: Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas. Mol Cancer Res 3: 403-412, 2005. (Pubitemid 41045590)
28. Aoki M, Nata T and Morishita R: Endothelial apoptosis induced by oxidative stress through activation of NF-κB: antiapoptotic effect of antioxidant agents on endothelial cells. Hypertension 38: 48-55, 2001. (Pubitemid 34224770)